DOYLE JOHN BRENDAN (Chief Financial Officer) reported 1 transaction at COGNITION THERAPEUTICS INC
Review the transaction codes below to understand the nature of each event.
Filed: 5/2/2025ACC: 0001062993-25-008394
Officer· Chief Financial Officer
Since Feb 2026
-9.69K
Net shares
Net seller
$4.3K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
9.69K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−9.69K
Price / share
$0.45
Trade value
$4.33K
% of position
2.3%
5/1/2025
414.40K→404.71K
Total
Net shares
−9.69K
Net value
-$4.33K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2025 | F · Tax Withholding | −9.69K | $0.45 | $4.33K | 2.3% | 414.40K | 404.71K |
| Total | −9.69K | -$4.33K | ||||||
Derivative Transactions0
No derivative transactions reported